Bionano Genomics Q3 EPS $(1.59) Beats $(1.91) Estimate, Sales $7.367M Beat $6.871M Estimate
Benzinga Newsdesk 11 months ago
EarningsEarnings BeatsNews
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.91) by 16.75 percent. This is a 94.86 percent increase over losses of $(30.92) per share from
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.91) by 16.75 percent. This is a 94.86 percent increase over losses of $(30.92) per share from the same period last year. The company reported quarterly sales of $7.367 million which beat the analyst consensus estimate of $6.871 million by 7.22 percent. This is a 21.31 percent increase over sales of $6.073 million the same period last year.